Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp > More Share Bought by Profound Medical's management

<< Previous

Bullboard Posts

Next >>

Post by Charlie263on May 18, 2022 12:04am

457 Views

Post# 34691311

More Share Bought by Profound Medical's management

It's important to note that following purchases has been made in the month of May 2022:
Arun Menawat puchased 60516 shares, in addition to his previous puchases in Mar 2022
Brian Ellacott purchased 50000 shares
Ken Knudson Purchased 8000 shares.

It seems Profound medical's team did spectecular presentations of TULSA PRO at AUA. To me it seems, the rise of Profound Medical is imminent.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?